Cellectar Biosciences
(NASDAQ) CLRB
Cellectar Biosciences Financials at a Glance
Market Cap
$10.77M
Revenue (TTM)
$0.00
Net Income (TTM)
$21.79M
EPS (TTM)
$-10.34
P/E Ratio
-0.25
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$2.47
Volume
0
Open
$2.73
Price
$2.47
Volume
0
Open
$2.73
Previous Close
$2.47
Daily Range
$2.47 - $2.80
52-Week Range
$2.45 - $20.59
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$2.47
Volume
0
Open
$2.73
Previous Close
$2.47
Daily Range
$2.47 - $2.80
52-Week Range
$2.45 - $20.59
CLRB News
CLRB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cellectar Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
James V. Caruso
Website
www.cellectar.comHeadquarters
Florham Park, NJ 07932, US
CLRB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-170%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-4.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.77M
Shares Outstanding
4.24M
Volume
0
Short Interest
0.00%
Avg. Volume
69.19K
Financials (TTM)
Gross Profit
$213.60K
Operating Income
$22.98M
EBITDA
$22.77M
Operating Cash Flow
$23.12M
Capital Expenditure
$5.88K
Free Cash Flow
$23.12M
Cash & ST Invst.
$13.20M
Total Debt
$409.59K
Cellectar Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$49.46K
N/A
Gross Margin
0.00%
N/A
Market Cap
$10.77M
N/A
Market Cap/Employee
$979.08K
N/A
Employees
11
N/A
Net Income
$5.30M
-124.8%
EBITDA
$5.64M
+55.5%
Quarterly Fundamentals
Net Cash
$12.79M
-43.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$309.40K
-24.5%
Short Term Debt
$100.19K
+18.7%
Return on Assets
-1.45%
N/A
Return on Invested Capital
-2.25%
N/A
Free Cash Flow
$4.35M
+60.4%
Operating Cash Flow
$4.34M
+60.2%